Vimseltinib Dihydrate

Placeholder slot

(vim-SEL-tih-nib dy-HY-drayt)

This page contains brief information about vimseltinib dihydrate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Romvimza

FDA Approved

Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Vimseltinib dihydrate is approved to treat adults with:

tenosynovial giant cell tumor that is causing symptoms. It is used when surgery may make the symptoms worse or cause severe problems.

Vimseltinib dihydrate is also being studied in the treatment of other conditions related to cancer.

More About Vimseltinib Dihydrate

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Therapy to Treat Cancer

Clinical Trials Accepting Patients

Find Clinical Trials for Vimseltinib Dihydrate - Check for trials from NCI's list of cancer clinical trials now accepting patients.